Dong Wha Pharm signs exclusive sales agreement of Plavix to clinics in Korea with Sanofi-Aventis
Dong Wha Pharm(CEO Ji-Hoon Sohn) signed an exclusive distribution and sales agreement of Plavix(generic name: clopidogrel bisulfate), an anti-platelet drug, to Korean clinics with Sanofi.Aventis Korea(CEO Kyung-Eun Bae). Under the agreement, Dong Wha Pharm has taken charge in sales and marketing ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
